Eloxx Pharmaceuticals is a biopharmaceutical company engaged in the science of ribosome modulation, utilizing both its TURBO-ZM™ chemistry technology platform and its library of aminoglycosides to develop oral small molecule Ribosome Modulating Agents and Eukaryotic Ribosome Selective Glycosides. Co. has various programs in its pipeline including a clinical program for the treatment of Alport syndrome with ELX-02, preclinical programs in investigational new drug (IND) enabling stages in Recessive Dystrophic and Junctional Epidermolysis Bullosa and Familial Adenomatous Polyposis with ZKN-013, and IND enabling stage program with inhaled delivery of ELX-02 in Class 1 cystic fibrosis. We show 25 historical shares outstanding datapoints in our ELOX shares outstanding history coverage, used to compute ELOX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ELOX market cap history over the course of time is important for investors
interested in comparing ELOX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ELOX versus a peer is one thing; comparing
ELOX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ELOX can fluctuate over the course of history.
With this page we aim to empower investors researching ELOX by allowing them to research the ELOX market cap history. |
Free ELOX Email Alerts:
Video: The Importance of Market Cap
